Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Clopamide→

Clopamide Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
636-54-4
Molecular formula
C14H20ClN3O3S
Molecular weight
345.8 g/mol
Drug class
Thiazide-like diureticsodium-chloride cotransporter inhibitor
Mechanism of action
Inhibits sodium and chloride reabsorption in the distal convoluted tubule, increasing urinary excretion of sodium and water and causing secondary potassium loss.
Indications / reported uses
  • Treatment of hypertension and oedema in countries where clopamide-containing products are authorised; fixed-combination indications depend on the partner active substances and local label

Sources: NLM MeSH — Clopamide · PubMed — Clopamide thiazide diuretic · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Clopamide Environmental Risk Assessment (ERA) (the Clopamide ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.